83
45
Growth Score
-3 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
473070
Gilboa Therapeutics is a next-generation cancer immunotherapy company developing novel T cell therapies for solid cancers.
Itamar Levy: COO- Shahar Dotan: R&D Director
About the Company
Gilboa Therapeutics a next-generation cancer immunotherapy company focused on the development of novel and transformative cell therapies designed to harness the power of a patient's own immune system to more effective treat a wide range of cancer types, with a mission to dramatically improve patient outcomes and save lives.
